Plasma lipidomic and metabolomic profiles in high‐grade glioma patients before and after 72‐h presurgery water‐only fasting
Molecular Oncology · 2025-08 · 19 (8) · 2249-2269
DOI: 10.1002/1878-0261.70003 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Molecular Oncology, online erschienen am 24.02.2025. Verfasst von Iris Divé und 7 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Senckenberg Institute of Neurooncology, Goethe University Frankfurt, University Hospital, Germany. Hauptthemen laut MEDLINE: Brain Neoplasms, Fasting, Glioma, Lipidomics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, LOEWE CePTER Center for Personalized Translational Epilepsy Research.
Abstract (Originalsprache)
Glioblastoma (GB) is the most aggressive primary brain tumor with poor prognosis despite multimodal therapy. Calorie‐restricted diets have emerged as putative strategies to augment anticancer therapies. We employed UHPLC‐high‐resolution mass spectrometry analyses of plasma lipids and polar metabolites to assess the systemic metabolic effects of a 72‐h preoperative fasting period in IDH‐wild‐type glioma patients ( n = 9 GB and n = 1 diffuse pediatric‐type high‐grade H3/IDH‐wildtype) who participated in the prospective ERGO3 trial (NCT04461938). Fasting reduced lysophosphatidylcholines (LPC, LPC‐O), lysophosphatidylethanolamines (LPE, LPE‐O), and increased free fatty acids and carnitines. Triglyceride (TG) profiles shifted from short‐chain TGs (42–48 C‐atoms) to very long‐chain TGs (58–60 C‐atoms) indicating an exploitation of neutral lipid stores. Branched‐chain amino acids, aminobutyric acid, and uric acids were increased, and glucose reduced after fasting. The effects of fasting were comparable in men and women. To our knowledge, this is the first study that evaluated the effects of fasting on systemic lipid/metabolite levels in GB patients. Our results may hold promise for integrating fasting interventions as a component of a potential metabolic tumor therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dr. Senckenberg Institute of Neurooncology, Goethe University Frankfurt, University Hospital, Germany.
- Center for Personalized Translational Epilepsy Research (CePTER), Goethe-University Frankfurt, University Hospital, Germany.
- University Cancer Center Frankfurt (UCT), Goethe University Frankfurt, University Hospital, Germany.
- German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, a partnership between DKFZ and University Hospital Frankfurt, Germany.
- Institute for Clinical Pharmacology, Faculty of Medicine, Goethe University Frankfurt, Germany.
- Fraunhofer Institute for Translational Medicine and Pharmacology ITMP and Fraunhofer Cluster of Excellence for Immune Mediated Diseases CIMD, Frankfurt am Main, Germany.
ORCID-Profile: Iris Divé, Lisa Hahnefeld, Katharina J Wenger, Donat Kögel, Joachim Steinbach, Gerd Geisslinger, Michael W Ronellenfitsch, Irmgard Tegeder
Förderung
- Deutsche Forschungsgemeinschaft
- LOEWE CePTER Center for Personalized Translational Epilepsy Research
Zitieren
APA
Divé, I., Hahnefeld, L., Wenger, K. J., Kögel, D., Steinbach, J., Geisslinger, G., Ronellenfitsch, M. W., & Tegeder, I. (2025). Plasma lipidomic and metabolomic profiles in high‐grade glioma patients before and after 72‐h presurgery water‐only fasting. Molecular Oncology, 19(8), 2249-2269. https://doi.org/10.1002/1878-0261.70003
Vancouver
Divé I, Hahnefeld L, Wenger KJ, Kögel D, Steinbach J, Geisslinger G, et al. Plasma lipidomic and metabolomic profiles in high‐grade glioma patients before and after 72‐h presurgery water‐only fasting. Molecular Oncology. 2025;19(8):2249-2269. doi:10.1002/1878-0261.70003
BibTeX
@article{Div2025,
author = {Divé, Iris and Hahnefeld, Lisa and Wenger, Katharina J and Kögel, Donat and Steinbach, Joachim and Geisslinger, Gerd and Ronellenfitsch, Michael W and Tegeder, Irmgard},
title = {Plasma lipidomic and metabolomic profiles in high‐grade glioma patients before and after 72‐h presurgery water‐only fasting},
journal = {Molecular Oncology},
year = {2025},
volume = {19},
number = {8},
pages = {2249--2269},
doi = {10.1002/1878-0261.70003}
}
EUVIMED